Sahajanand Medical Technologies IPO Details Details

Sahajanand Medical Technologies IPO is a book-built issue worth ₹475.48 crore, comprising entirely an Offer for Sale (OFS) of 1.38 crore shares. The IPO opens on October 15, 2026, and closes on October 19, 2026. Allotment is expected on October 21, with a tentative NSE and BSE listing on October 23, 2026. The price band is ₹327–₹344 per share, with a lot size of 43 shares and a minimum retail investment of ₹14,792. Lead Manager: Motilal Oswal Investment Advisors Ltd. Registrar: MUFG Intime India Pvt. Ltd.

IPO Details

IPO Date 15 Oct 26
Listing Date 23 Oct 26
Face Value ₹1 per share
Price Band ₹327 to ₹344
Lot Size 43
Sale Type OFS only
Issue Type Bookbuilding IPO
Listing At NSE, BSE
Total Issue Size ₹475 Cr
Fresh Issue
Offer for Sale
Share Holding Pre Issue 10,16,46,778 shares
Share Holding Post Issue 10,16,46,778 shares

IPO DRHP Status

Description Details

IPO Reservation

Investor Category Shares Offered
QIB Shares Offered Not more than 50% of the Net Offer
Retail Shares Offered Not less than 35% of the Net Offer
NII Shares Offered Not less than 15% of the Net Offer

About Sahajanand Medical Technologies IPO Details.


Sahajanand Medical Technologies Limited, incorporated in October 2001, is a medical technology company specializing in advanced cardiovascular devices, including coronary stents, balloons, TAVI devices, occluders and peripheral drug-coated balloons. Its key brands include Supraflex Cruz, Cocoon and Hydra. The company operates 3 manufacturing facilities (2 in India and 1 in Thailand) and 2 R&D centres. As of June 2026, it held 119 granted patents globally, with 78 pending applications. Its products were marketed across 77 countries in FY26. Revenue increased from ₹901.60 crore in FY24 to ₹1,210.50 crore in FY26. The company had 1,605 full-time employees as of June 2026. Competitive Strengths: Strong global presence and distribution network. Advanced R&D and patented technologies. Diversified manufacturing capabilities. Established position in cardiovascular medical devices. Experienced management and strategic partnerships.

Company Financials (Restated)

Period Ended 30 Jun 2026 31 Mar 2026 31 Mar 2025
Assets 1,309.00 1,276.43 1,094.90
Total Income 354.33 1,218.73 1,035.96
Profit After Tax 15.09 69.08 25.15
EBITDA 48.58 170.66 128.02
Net Worth 631.72 616.05 545.23
Amount in ₹ Crore

IPO Objects of the Issue

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:

# Issue Objects Est Amt (₹ Cr.)
1 The Sahajanand Medical Technologies Ltd. IPO is a 100% Offer for Sale (OFS), so the company will not receive any funding and the entire IPO proceeds will go to the selling shareholders. 0.00

Key Performance Indicator (KPI)

KPI Jun 30, 2026 Mar 31, 2026
ROE 2.07%% 10.35%%
ROCE 3.16%% 11.57%%
Debt/Equity - -
RoNW 2.31%% 10.60%%
PAT Margin 4.29%% 5.71%%
EBITDA Margin 13.81%% 14.10%%

Key Performance Indicator (KPI)

Pre IPO Post IPO
EPS Rs 6.80 5.94
The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue The Pre IPO EPS is calculated based on Pre issue shareholding as on date of RHP and the latest FY earnings as of March 31, 2026 available in RHP. The Post Issue EPS is calculated based on the Post issue shareholding and annualized FY earnings of June 30, 2026 available in RHP.

IPO Registrar

  • MUFG Intime India Pvt.Ltd.
  • 022-49186000
  • sahajanandmedical.ipo@in.mpms.mufg.com
  • Visit Website

Contact Details

Sahajanand Medical Technologies Ltd. Address
Sahajanand Estate, Wakharia Wadi, NR. Dabholi Char Rasta Nani Ved, Ved Road Surat, Gujarat, 395004

IPO FAQs

  • What is the Aureate Tradde IPO?

    Aureate Tradde IPO is a SME IPO of 38,98,000 equity shares of the face value of ₹10 aggregating up to ₹[.] Crores. The issue is priced at To be declared. The minimum order quantity is . The Aureate Tradde IPO open and close dates are not available as of now. MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE SME.

  • How to apply in Aureate Tradde IPO through Zerodha?

    Zerodha customers can apply online in Aureate Tradde IPO using UPI as a payment gateway. Zerodha customers can apply in Aureate Tradde IPO by login into Zerodha Console (back office) and submitting an IPO application form.

    Steps to apply in Aureate Tradde IPO through Zerodha

    1. Visit the Zerodha website and login to Console.
    2. Go to Portfolio and click the IPOs link.
    3. Go to the ' Aureate Tradde IPO ' row and click the 'Bid' button.
    4. Enter your UPI ID, Quantity, and Price.
    5. Submit IPO application form.
    6. Visit the UPI App (net banking or BHIM) to approve the mandate.

    Visit Zerodha IPO Application Process Review for more detail.

  • When Aureate Tradde IPO will open?

    The Aureate Tradde IPO dates are not announced. Please check back again after some time.

  • What is the lot size of Aureate Tradde IPO?

    Aureate Tradde IPO lot size and the minimum order quantity is not available at this time. Please check again later.

  • How to apply for Aureate Tradde IPO?

    You can apply in Aureate Tradde IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.

  • Is online banking secure?

    Repudiated and annoyances accepted the wise man therefore always holds in these matters to this principle selection he rejects pleasures to secures.

  • When is Aureate Tradde IPO allotment?

    The finalization of Basis of Allotment for Aureate Tradde IPO will be done on [.], and the allotted shares will be credited to your demat account by . Check the Aureate Tradde IPO allotment status.

  • When is Aureate Tradde IPO listing date ?

    The Aureate Tradde IPO listing date is not yet announced. The tentative date of listing is .